KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShares OutstandingShares Repurchased
Ratios

Sarepta Therapeutics (SRPT) Long-Term Debt Repayments (2016 - 2018)

Historic Long-Term Debt Repayments for Sarepta Therapeutics (SRPT) over the last 8 years, with Q4 2018 value amounting to $17.3 million.

  • Sarepta Therapeutics' Long-Term Debt Repayments rose 412.33% to $17.3 million in Q4 2018 from the same period last year, while for Dec 2023 it was $17.3 million, marking a year-over-year decrease of 7219.47%. This contributed to the annual value of $550.0 million for FY2022, which is N/A changed from last year.
  • Per Sarepta Therapeutics' latest filing, its Long-Term Debt Repayments stood at $17.3 million for Q4 2018, which was up 412.33% from $45.0 million recorded in Q3 2018.
  • Sarepta Therapeutics' Long-Term Debt Repayments' 5-year high stood at $100.1 million during Q1 2018, with a 5-year trough of -$2.5 million in Q4 2016.
  • Its 5-year average for Long-Term Debt Repayments is $14.8 million, with a median of $2.5 million in 2015.
  • As far as peak fluctuations go, Sarepta Therapeutics' Long-Term Debt Repayments crashed by 999200.0% in 2016, and later skyrocketed by 23278837.21% in 2018.
  • Over the past 5 years, Sarepta Therapeutics' Long-Term Debt Repayments (Quarter) stood at $23000.0 in 2014, then increased by 8.7% to $25000.0 in 2015, then tumbled by 9992.0% to -$2.5 million in 2016, then skyrocketed by 772.75% to $16.6 million in 2017, then grew by 4.12% to $17.3 million in 2018.
  • Its Long-Term Debt Repayments stands at $17.3 million for Q4 2018, versus $45.0 million for Q3 2018 and $73.5 million for Q2 2018.